Dublin, June 18, 2025 (GLOBE NEWSWIRE) — The “Preventive Healthcare Technologies and Services Market Opportunities and Strategies to 2034” has been added to ResearchAndMarkets.com’s offering.
The global preventive healthcare technologies and services market reached nearly $296.5 billion in 2024, growing at a CAGR of 10.12% since 2019. Forecasts suggest significant growth, with projections reaching $617.8 billion by 2029 at a 15.82% CAGR and anticipated growth to $1.19 trillion by 2034 at a 14.16% CAGR.
Key growth drivers in the historical period included AI integration in diagnostics, the expansion of telemedicine, advancements in genomic medicine, and smart hospital technology implementation. Challenges like regulatory hurdles and innovation barriers impeded growth. Looking ahead, the integration of blockchain, expansion of health management solutions, growth in digital therapeutics, and public awareness will propel the market. However, data security concerns and healthcare access inequality may pose challenges.
In 2024, Asia-Pacific emerged as the largest region, commanding 31.93% of the market or $94.65 billion, followed by North America and Western Europe. Future growth hotspots include Asia-Pacific and the Middle East, projected at 17.93% and 16.86% CAGRs, respectively, followed by South America and Africa with 16.49% and 15.71% CAGRs.
The market remains fragmented, with top ten players capturing only 4.23% of the market in 2023. GlaxoSmithKline (GSK) led with a 0.99% share, followed by Abbott Laboratories, Medtronic plc, Becton Dickinson (BD), and others.
The market segments by type into early detection and screening technologies, vaccines, chronic disease management, and advanced error-reducing technologies. The early detection and screening segment led in 2024, accounting for 36.70% of the market. The chronic disease management sector is the fastest growing, with an 18.15% CAGR expected from 2024-2029.
By application, hospitals dominated the market in 2024, accounting for 60.13% or $178.26 billion of the market. The clinics segment is forecasted to grow fastest at a 16.83% CAGR during 2024-2029. Notable opportunities include the early detection segment projected to generate $125.8 billion in global annual sales by 2029 and the hospitals sector with expected sales growth of $182.2 billion. The US market is anticipated to expand by $72.29 billion.
Current market trends encompass AI-driven early disease detection, telemedicine expansion, wearable health device proliferation, digital twin technology for personalized care, gut microbiome testing for nutrition, and workplace health programs expansion with biometrics.
Strategic directions for market players include enhancing global reach through competitive pricing, strategic product launches, and fostering partnerships for diagnostic improvements. To seize opportunities, it is advisable to focus on AI-driven early detection, wearable tech integration, digital twin incorporation, personalized gut microbiome testing, corporate wellness solutions expansion, and increased market penetration through digital initiatives.
Major Market Trends:
- Integration of Artificial Intelligence in Early Disease Detection
- Expansion of Telemedicine and Mobile Health (mHealth) Services
- Proliferation of Wearable Health Monitoring Devices
- Adoption of Digital Twin Technology for Personalized Preventive Care
- Rise of Gut Microbiome Testing for Preventive Nutrition
- Expansion of Workplace Preventive Health Programs Using Biometrics
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 293 |
| Forecast Period | 2024 – 2034 |
| Estimated Market Value (USD) in 2024 | $296.47 Billion |
| Forecasted Market Value (USD) by 2034 | $1190 Billion |
| Compound Annual Growth Rate | 15.0% |
| Regions Covered | Global |
Companies Featured
- GlaxoSmithKline (GSK)
- Abbott Laboratories
- Medtronic plc
- Becton Dickinson (BD)
- Merck & Co. Inc.
- Koninklijke Philips N.V.
- McKesson Corporation
- Omnicell Inc.
- Sanofi SA
- Omron Healthcare Inc.
- Pro Medicus
- Sonic Healthcare
- ResMed
- Mindray
- WeDoctor
- Ping An Good Doctor
- AliHealth
- CitiusTech
- PharmEasy
- 1mg
- Halodoc
- Alodokter
- KlikDokter
- SehatQ
- Olympus Corporation
- Terumo Corporation
- Hoya Corporation
- Sysmex Corporation
- Nihon Kohden
- Doctor Anywhere
- WhiteCoat
- Homage
- Vuno
- AItrics
- LifeSemantics
- MediHeroes
- HUINNO Healthcare
- Siemens Healthineers
- Philips Healthcare
- Cera Care
- HealthHero
- Neko Health
- Tolion Health, Inc.
- Prosoma
- CliniNote
- Roche
- Nanonets Health
- Zebra
- Lyra Health
- Spring Health
- Headspace
- PointClickCare
- Fullscript
- AlayaCare
- Momentum Health
- Uala
- Naranja X
- Nubank
- Banco Bradesco
- Banco Santander
- Banco Falabella
- Excel Credit
- Banco de Credito del Peru (BCP)
- Banco Falabella Per
- Teva Pharmaceuticals
- Medtronic
- Check-Cap
- Insightec
- Cerner Middle East
- Medcare Hospitals & Medical Centres
- Aster DM Healthcar
- Sehatech
- Vezeeta
- Hi Pharma
- CureMD
- Mediclinic International
For more information about this report visit https://www.researchandmarkets.com/r/oj8qx9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Preventive Healthcare Technologies and Services Market
